Dong-a St Co., Ltd.

This study tests a new medicine called DA-5218 in 238 adults with type 2 diabetes whose blood sugar is still too high despite taking metformin. Participants will receive either DA-5218 or an active comparator to see which better lowers HbA1c over 8 weeks. The goal is to improve b…

This early-phase study tests a new drug called DA-3501 in people with advanced stomach, gastro-esophageal junction, or pancreatic cancers that have a specific marker (CLDN18.2). The main goals are to find the safest dose and see if the drug can shrink tumors. About 51 adults will…

This study tests a new medicine called DA-2811 for people with type 2 diabetes whose blood sugar is not well controlled with their current two-drug combination. About 288 adults will either add DA-2811 or a placebo to their existing treatment. The goal is to see if the new drug h…

This study aims to see if two versions of a drug, DA-5230 and DA-5230-R, are absorbed and processed by the body in the same way. It will involve 60 healthy adults aged 19 to 55. Participants will receive a single dose of each drug on separate days, and blood samples will be taken…